Browse by category

Sirona - a dual-polymer hydrogel pill - could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. Sirona developed by Oxford Medical Products is a hydrogel-based pill that is designed to aid weight loss by reducing hunger. After it is swallowed, the pill expands in your stomach, making you feel full faster. This helps you eat less without needing strong medications or injections. In th

Ascletis Pharma has completed enrolment in the US Phase IIa study for its once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule GLP-1 receptor (GLP-1R) agonist ASC30 for the treatment of obesity. All 65 participants are obese or overweight with at least one weight-related comorbidity. The Phase IIa study of ASC30 once-monthly SQ depot treatment formulation is a 12-week, randomised, double-blind, placebo-controlled and multi-centre study co

Novo Nordisk has received FDA approval for Rybelsus for reducing the risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they've had a prior CV event or not (primary and secondary prevention). Results of the SOUL trial reinforce the clinical profile of the semaglutide molecule, which has been studied across a variety of therapeutic areas. "Ev

The global anti-obesity drug market is estimated to increase in valve to $25.87 billion in 2025 and is expected to reach $82.55 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.01% from 2025 to 2032.  This strong market growth is driven by the rising global prevalence of obesity and the increasing demand for effective pharmaceutical treatments, according to a re[ort by According to Coherent Market Insights (CMI). Additionally, advancements in drug formul

A patient’s decision to undergo bariatric surgery is often driven by a combination of complex factors such as health concerns, impaired quality of life and societal pressure, according to researchers from the University College Cork, Cork, Ireland. They found that health concerns were the primary motivator, with participants seeking to address comorbidities, mitigate health risks, and enhance their quality of life. In addition, body image, psychological well-being, and resist

Blood tests taken before bariatric surgery were associated with blood pressure readings five years later, according to a study from the Keck School of Medicine of USC and Ann & Robert H Lurie Children’s Hospital of Chicago. A USC-led team has developed an innovative way to predict blood pressure outcomes after bariatric surgery that outperforms the current standard practice. In 108 adolescents who underwent bariatric surgery, the researchers used blood tests taken before the